Status:
COMPLETED
COVID SAFE: COVID-19 Screening Assessment for Exposure
Lead Sponsor:
University of Pennsylvania
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balan...
Detailed Description
The coronavirus disease 2019 (COVID-19) pandemic has resulted in close to 10,000,000 reported cases worldwide, including more than 2,000,000 aggregated reported cases and 120,000 deaths in the United ...
Eligibility Criteria
Inclusion
- Be 18 years or older
- University of Pennsylvania faculty, staff, or trainee
- Have a phone or device capable of receiving text messages
- Willing to participate in the study for 6 months
Exclusion
- Participants will not be eligible if they identify any reason they are unable to participate in the study.
Key Trial Info
Start Date :
September 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 23 2021
Estimated Enrollment :
1759 Patients enrolled
Trial Details
Trial ID
NCT04508777
Start Date
September 9 2020
End Date
June 23 2021
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Medicine
Philadelphia, Pennsylvania, United States, 19103